Mansukh Mandaviya urges pharma industry to work towards increasing share of generic drugs in India

NEW DELHI: Union health minister Mansukh Mandaviya on Thursday urged the pharma industry to consider domestic manufacturing of medicines which are soon going to be off patent under Atmanirbhar Bharat and also to work towards increasing the share of generic drugs in the country.

He was addressing a session on ‘Ensuring Affordable, Accessible Health for All’ at the CII Annual Meeting 2021.

The minister urged the pharma industry to consider domestic manufacturing of medicines which are soon going to be off patent and said the PLI scheme announced by the government would help the domestic industry in this endeavour.

He said initiatives such as the medical devices park, pharma park, PLI will help the industry to grow in the coming days.

He also assured the industry of all possible support to improve health infrastructure and sought cooperation and inputs to improve ease of doing business and competitiveness of this sector.

The government and industry partnership to make healthcare accessible and affordable assumes importance in a country like India as sickness increases the cost for the poor and impedes progress, the minister who holds the charge of the Ministry of Chemicals and Fertilizers said.

“If any country has to prosper, among many parameters, one is that the citizens of the country have to be healthy and for that health facilities have to be affordable and accessible,” he said.

The minister lauded the private sector for working in tandem with the government to meet the shortage of healthcare facilities, oxygen, injections, medicines etc during the pandemic.

Many companies repurposed their processes for production of critical care health requirements on a large scale, including masks, PPEs, and ventilators, he said.

Speaking about initiatives for providing affordable healthcare, the minister mentioned the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and noted how the number of Janaushadhhi kendras had gone up to over 8,000 in 2016 from 103, while the number of medicines available at these stores had also increased.

It is a direct end to end chain with no middlemen, he said, adding the private sector is also participating in this initiative by submitting tenders.

Alluding to the Ayushman Bharat insurance scheme, he said over 2 crore families have benefitted from it and private hospitals are also participating in the mission.

The minister said in a democratic system, when people and government work together only then the country can prosper. The best example of how the corporate sector and industries can work together and give output was seen during the COVID-19 crisis management, he added.

About the first lockdown which was imposed nationwide following an announcement by Prime Minister Narendra Modi, he said it was imposed as India did not have PPE kits, ventilators, also drugs were not available in enough qualities, and people were not trained and did not have the experience.

In a country like India, despite the huge diversity and different strata of people, migration and other situations, the lockdown was imposed for one and half months and everybody worked collectively to make it successful, Mandaviya said.

The government did its part, industries did whatever they could for their employees, NGOs did whatever they could do, and people and families took care of each other in the community and neighbourhood. Whereas even in several developed countries, people had agitated against the lockdown, Mandaviya pointed out.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad